Buyer profile

Eli Lilly and Company

Every published deal in the Exit Mode archive where this buyer appears on the acquiring side.

Country

United States

Deal count

2

Buyer type

Corporate / other

Aggregate disclosed value

Not stated

8 September 2026CompletedHealthcare

Eli Lilly and Company to acquire Sangamo Therapeutics, Inc.

Eli Lilly and Company and Sangamo Therapeutics, Inc. entered the Exit Mode archive.

Buyer: Eli Lilly and Company
Target: Sangamo Therapeutics, Inc.
Deal value: USD 50,000,000
Deal type: asset sale

Read deal Healthcare deals asset sale deals United States deals

15 July 2026CompletedHealthcare

Eli Lilly and Company to acquire AtaiBeckley Inc.

Eli Lilly and Company and AtaiBeckley Inc. entered the Exit Mode archive.

Buyer: Eli Lilly and Company
Target: AtaiBeckley Inc.
Deal value: Not disclosed
Deal type: going private

Read deal Healthcare deals going private deals United States deals

Keep browsing

Explore the archive from another angle

Explore sectors

Telecommunications Industrials Healthcare Technology Energy Real Estate

Browse by deal type

strategic acquisition unknown asset sale tender offer pe acquisition minority stake

Browse by region

United Kingdom United States Other regions Europe

Browse by country

United Kingdom United States Cayman Islands Austria Germany Indonesia

Browse by stage

In review Completed Announced Rumoured Abandoned

Year archives